Business

August 7, 2014

Chimerix reports $11.7M loss in second quarter

Chimerix posted a $11.7 million loss in the second quarter but also raised significant funds to finance the development of its lead drug candidate, brincidofovir.

Related content

Comments

Editor's Choice Videos